My research is focused on understanding how integrins help cancer cells invade and metastasise, as well as how we can use integrins as biomarkers of disease and therapeutic targets.
I am also co-ordinating a clinical trial using a novel integrin αvβ6-specific peptide to visualise metastases in breast cancer (IMETAB6).